Skip to content
GeneCraft Inc. logo — company profile

GeneCraft Inc.

Founded 2020 7 employees Series A Total: $10.00B Biopharma, Biotechnology

General Information

Company Name GeneCraft Inc.
Founded Year 2020
Employees 7
Industries Biopharma, Biotechnology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with GeneCraft Inc.. To contact GeneCraft Inc., visit genecraft.co.kr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GeneCraft Inc. compare?

A PDF of GeneCraft Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GeneCraft Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GeneCraft Inc.

GeneCraft Inc. is a pre-clinical-stage biotech company that was founded in 2020. The company is dedicated to improving treatment and clinical outcomes for patients through gene therapy that harnesses the innate oncogene defense system. The industries it operates in include Biopharma and Biotechnology. GeneCraft recently secured a KRW10.00B Series A investment on 15 January 2024. The investors involved in this round of funding include Seoul National University Technology Holdings, Cosine Investment, and InfoBank. This significant investment and support from these established investors indicate the promising potential of GeneCraft to make a substantial impact in the biotech industry.

Business keywords: biotech, pre-clinical-stage, gene therapy, oncogene defense system, treatment, clinical outcomes, gene editing, innovation, precision medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A KRW10.00B 3
Seoul National University Technology Holdings, Cosine Investment +1
15 Jan 2024

GeneCraft Inc. Alternatives & Competitors

View All Alternatives
GeneCraft Inc. vs

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improvi...

Post-IPO Secondary
196 employees
Biopharma, Biotechnology
GeneCraft Inc. vs
Genprex, Inc.
Genprex, Inc. United States

Genprex is a gene therapy company focused on developing life-changing technologies for patients with...

Post-IPO Equity
24 employees
Biopharma, Biotechnology
GeneCraft Inc. vs

辉大,给患者回答 | Answering the Patients!

Series C
27 employees
Biopharma, Biotechnology

FAQ About GeneCraft Inc.

GeneCraft is a pre-clinical-stage biotech company dedicated to improving treatment and clinical outcomes for patients through gene therapy that harness the innate oncogene defense system.
GeneCraft Inc. was founded in 2020.
GeneCraft Inc. operates in Biopharma and Biotechnology. Its work centres on biotech, pre-clinical-stage, gene therapy and oncogene defense system.
GeneCraft Inc. has approximately 7 employees.
GeneCraft Inc. has completed 1 funding round, raising a total of $10.00B. The latest funding stage is Series A.
Top alternatives and competitors to GeneCraft Inc. include Innate Pharma, Genprex, Inc., HuidaGene Therapeutics, Aurion Biotech, Genelux. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GeneCraft Inc. and Innate Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GeneCraft Inc., https://bouncewatch.com/company/genecraft-inc, updated 19 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout